Experienced in Choroid Plexus Carcinoma

Dr. Michael Schulder

Neurosurgery
North Shore-Lij Medical PC
300 Community Dr, 
Manhasset, NY 
Experienced in Choroid Plexus Carcinoma
North Shore-Lij Medical PC
300 Community Dr, 
Manhasset, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Schulder is a Neurosurgery provider in Manhasset, New York. Dr. Schulder is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy.

His clinical research consists of co-authoring 93 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in NJ
Hospital Affiliations
Long Island Jewish Medical Center
North Shore University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

NORTH SHORE-LIJ MEDICAL PC
300 Community Dr, Manhasset, NY 11030
Other Locations
NORTH SHORE-LIJ MEDICAL PC
330 Community Dr, Manhasset, NY 11030
NORTH SHORE-LIJ MEDICAL PC
350 Community Dr, Manhasset, NY 11030
NORTH SHORE-LIJ MEDICAL PC
450 Lakeville Rd, New Hyde Park, NY 11042

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Radiation, Procedure, Drug
Study Drug: Temozolomide
Study Phase: Phase 3
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Combination product, Procedure, Drug
Study Drugs: IGV-001 Cell Immunotherapy, Temozolomide
Study Phase: Phase 2
A Phase 1/2 Study of Selinexor in Combination With Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
A Phase 1/2 Study of Selinexor in Combination With Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: December 16, 2024
Intervention Type: Drug, Device, Radiation
Study Drugs: Selinexor, Temozolomide (TMZ), Lomustine (CCNU), Bevacizumab, Carmustine
Study Phase: Phase 1/Phase 2
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
Phase I Study of Subventricular Zone Tumor Stem Cell Stereotactic Radiosurgery With Standard of Care Chemoradiation Therapy in Newly Diagnosed Malignant Gliomas (WHO III and WHO IV Astrocytomas)
Phase I Study of Subventricular Zone Tumor Stem Cell Stereotactic Radiosurgery With Standard of Care Chemoradiation Therapy in Newly Diagnosed Malignant Gliomas (WHO III and WHO IV Astrocytomas)
Enrollment Status: Withdrawn
Publish Date: March 15, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

93 Total Publications

Artificial intelligence applications in the screening and classification of glioblastoma.
Artificial intelligence applications in the screening and classification of glioblastoma.
Journal: Journal of neurosurgical sciences
Published: July 15, 2025
Similar Doctors
Advanced in Choroid Plexus Carcinoma
Dr. Mark Bilsky
Neurosurgery
Advanced in Choroid Plexus Carcinoma
Dr. Mark Bilsky
Neurosurgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (13.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Bilsky is a Neurosurgery provider in New York, New York. Dr. Bilsky is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Vertebroplasty, and Laminectomy.

Experienced in Choroid Plexus Carcinoma
Dr. Celina M. Crisman
Neurosurgery
Experienced in Choroid Plexus Carcinoma
Dr. Celina M. Crisman
Neurosurgery

Montefiore Medical Center

111 E 210th St, 
Bronx, NY 
 (11.7 miles away)
Languages Spoken:
English
See accepted insurances

Celina Crisman is a Neurosurgery provider in Bronx, New York. Dr. Crisman is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. Her top areas of expertise are Chronic Subdural Hematoma, Subdural Hematoma, Apoplexy, Delirium, and Awake Craniotomy.

Experienced in Choroid Plexus Carcinoma
Dr. Ilya Laufer
Neurosurgery
Experienced in Choroid Plexus Carcinoma
Dr. Ilya Laufer
Neurosurgery

New York University

530 1st Ave, 
New York, NY 
 (14.5 miles away)
212-263-7300
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Ilya Laufer is a Neurosurgery provider in New York, New York. Dr. Laufer is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Vertebroplasty, and Bone Graft. Dr. Laufer is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schulder's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 11 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile